USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Feb 22, 2022 | Dec 2021 | $-1.15 | $-1.06 | $-0.94 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Feb 22, 2022 | Dec 2021 | $99.04M | $94.78M | $78.32M |
Guardant Health's next earnings date is Tuesday, Feb 22, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 12 | $-1.15 | $-1.28 | $-1.02 |
| Mar 2022 | 7 | $-1.12 | $-1.30 | $-1.01 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 12 | $-4.26 | $-4.40 | $-4.13 |
| Dec 2022 | 12 | $-4.34 | $-5.18 | $-3.58 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 3 / 1 | $-0.96 | $-0.96 | $-0.93 |
| Mar 2022 | 2 / 1 | $-0.92 | $-0.94 | $-0.88 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 3 / 1 | $-3.92 | $-3.92 | $-3.88 |
| Dec 2022 | 3 / 1 | $-3.34 | $-3.34 | $-3.19 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 12 | $99.04M | $96.46M | $102.00M |
| Mar 2022 | 9 | $106.15M | $99.10M | $114.00M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 14 | $364.70M | $361.22M | $369.02M |
| Dec 2022 | 14 | $474.71M | $453.90M | $508.00M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 22, 2022 | Dec 2021 | $-1.14 | - | - |
| Nov 4, 2021 | Sep 2021 | $-0.89 | $-1.06 | -18.75% |
| Aug 5, 2021 | Jun 2021 | $-0.83 | $-0.96 | -15.11% |
| May 6, 2021 | Mar 2021 | $-0.83 | $-1.09 | -31.23% |
| Feb 24, 2021 | Dec 2020 | $-0.47 | $-0.94 | -99.11% |
| Nov 5, 2020 | Sep 2020 | $-0.36 | $-0.78 | -118.73% |
| Aug 6, 2020 | Jun 2020 | $-0.36 | $-0.57 | -58.20% |
| May 7, 2020 | Mar 2020 | $-0.39 | $-0.29 | 25.20% |
| Feb 24, 2020 | Dec 2019 | $-0.30 | $-0.27 | 11.27% |
| Nov 7, 2019 | Sep 2019 | $-0.37 | $-0.14 | 62.56% |
| Aug 6, 2019 | Jun 2019 | $-0.35 | $-0.13 | 62.84% |
| May 9, 2019 | Mar 2019 | $-0.37 | $-0.30 | 18.79% |
| Mar 12, 2019 | Dec 2018 | $-0.35 | $-0.30 | 14.94% |
| Nov 19, 2018 | Sep 2018 | $-0.29 | $-0.29 | 3.06% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 24, 2021 | Dec 2020 | $-2.21 | $-2.58 | - |
| Feb 24, 2020 | Dec 2019 | $-0.88 | $-0.84 | - |
| Mar 12, 2019 | Dec 2018 | $-1.59 | $-0.59 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 22, 2022 | Dec 2021 | $99.04M | - | - |
| Nov 4, 2021 | Sep 2021 | $92.64M | $94.78M | 1.02% |
| Aug 5, 2021 | Jun 2021 | $84.61M | $92.10M | 1.09% |
| May 6, 2021 | Mar 2021 | $78.67M | $78.67M | 1.00% |
| Feb 24, 2021 | Dec 2020 | $76.73M | $78.32M | 1.02% |
| Nov 5, 2020 | Sep 2020 | $65.93M | $74.57M | 1.13% |
| Aug 6, 2020 | Jun 2020 | $59.17M | $66.33M | 1.12% |
| May 7, 2020 | Mar 2020 | $56.47M | $67.51M | 1.20% |
| Feb 24, 2020 | Dec 2019 | $54.83M | $62.90M | 1.15% |
| Nov 7, 2019 | Sep 2019 | $45.42M | $60.85M | 1.34% |
| Aug 6, 2019 | Jun 2019 | $36.43M | $53.98M | 1.48% |
| May 9, 2019 | Mar 2019 | $31.65M | $36.66M | 1.16% |
| Mar 12, 2019 | Dec 2018 | $24.90M | $32.87M | 1.32% |
| Nov 19, 2018 | Sep 2018 | $17.50M | $21.69M | 1.24% |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 24, 2021 | Dec 2020 | $284.84M | $286.73M | 0.66% |
| Feb 24, 2020 | Dec 2019 | $206.22M | $214.38M | 3.95% |
| Mar 12, 2019 | Dec 2018 | $81.67M | $90.64M | 10.98% |
GH's next earnings date is Tuesday, Feb 22, 2022 for the fiscal quarter ending Dec 31, 2021.
According to 12 analysts, the average EPS estimation for Guardant Health's next quarterly earnings is $-1.15, with a low EPS estimation of $-1.28, and a high estimation of $-1.02.
Over the last 1 month, EPS estimates have seen 3 upward revisions and 1 downward. The EPS 1 month trend is $-0.96, the last 2 month trend is $-0.96, and the 3 month trend is $-0.93.
Based on 13 analysts, the average revenue estimation is $99.04M, with a low revenue estimation of $96.46M, and a high estimation of $102.00M.
Guardant Health's previous earnings date was Nov 4, 2021 for its fiscal quarter ended Sep 30, 2021.
GH's earnings per share (EPS) was $-1.06, missing the consensus analysts forecast of $-0.89 by -18.75%.
The EPS was lower than the previous fiscal quarter (Jun 2021) by 10.42%, and lower than the same period a year before (Sep 2020) by 35.90%.
Revenues were $94.78M, better than the forecast of $92.64M by 2.31%, up by 2.91% from the previous quarter , and up by 27.10% from the same period last year.
The company reported a net income of $-107.53M.Free cash flow for the quarter was $-75.29M , compared to $-81.27M last quarter and $-17.84M a year before.
GH ended the quarter with $1.36B in total debt, an increase of 0.47% compared to the previous quarter, and an increase of 2784.63% compared to the same quarter a year before.
Guardant Health's previous annual earnings date was Feb 24, 2021 for its fiscal year ended Dec 31, 2020.
GH's earnings per share (EPS) was $-2.58, missing the consensus analysts forecast of $-2.21 by 16.74% , and lower than the previous year's EPS (Dec 2019) by 207.14%.
Revenues were $286.73M, better than the forecast of $284.84M by 0.66%, and up by 33.75% from previous year's revenue.
The company reported a net income of $-253.78M.
Guardant Health reported a free cash flow of $-157.99M for its fiscal year, compared to $-68.35M a year ago.
The company ended the fiscal year with $812.92M in total debt, an increase of 1912.39% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
